More articles from Pharmacology and Therapeutics

You have access
SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover Trial
Katrine M. Lauritsen, Bent R.R. Nielsen, Lars P. Tolbod, Mogens Johannsen, Jakob Hansen, Troels K. Hansen, Henrik Wiggers, Niels Møller, Lars C. Gormsen, Esben Søndergaard

Diabetes Mar 2021, 70 (3) 800-808; DOI: 10.2337/db20-0921
You have access
Dapagliflozin Suppresses ER Stress and Improves Subclinical Myocardial Function in Diabetes: From Bedside to Bench
Jhih-Yuan Shih, Yu-Wen Lin, Sudeshna Fisch, Juei-Tang Cheng, Nai-Wen Kang, Chon-Seng Hong, Zhih-Cherng Chen, Wei-Ting Chang

Diabetes Jan 2021, 70 (1) 262-267; DOI: 10.2337/db20-0840
Open Access
Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy
Gemma V. Brierley, Hannah Webber, Eerika Rasijeff, Sarah Grocott, Kenneth Siddle, Robert K. Semple

Diabetes Nov 2020, 69 (11) 2481-2489; DOI: 10.2337/db20-0345
Open Access
Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
Matthew J. Singleton, Elsayed Z. Soliman, Alain G. Bertoni, S. Patrick Whalen, Prashant D. Bhave, Joseph Yeboah

Diabetes Oct 2020, 69 (10) 2186-2193; DOI: 10.2337/db20-0401
You have access
A Small Molecule, UAB126, Reverses Diet-Induced Obesity and its Associated Metabolic Disorders
Guang Ren, Teayoun Kim, Hae-Suk Kim, Martin E. Young, Donald D. Muccio, Venkatram R. Atigadda, Samuel I. Blum, Hubert M. Tse, Kirk M. Habegger, Sushant Bhatnagar, Tatjana Coric, Mary-Ann Bjornsti, Anath Shalev, Stuart J. Frank, Jeong-a Kim

Diabetes Sep 2020, 69 (9) 2003-2016; DOI: 10.2337/db19-1001
Open Access
GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers
Alexander S. Christensen, Sofie Hædersdal, Heidi Storgaard, Kathrine Rose, Nina L. Hansen, Jens J. Holst, Torben Hansen, Filip K. Knop, Tina Vilsbøll

Diabetes Sep 2020, 69 (9) 1989-2002; DOI: 10.2337/db20-0074
Open Access
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
Jay M. Sosenko, Jay S. Skyler, Kevan C. Herold, Desmond A. Schatz, Michael J. Haller, Alberto Pugliese, Mario Cleves, Susan Geyer, Lisa E. Rafkin, Della Matheson, Jerry P. Palmer

Diabetes Aug 2020, 69 (8) 1827-1832; DOI: 10.2337/db20-0166
You have access
Connecting Rodent and Human Pharmacokinetic Models for the Design and Translation of Glucose-Responsive Insulin
Jing Fan Yang, Xun Gong, Naveed A. Bakh, Kelley Carr, Nelson F.B. Phillips, Faramarz Ismail-Beigi, Michael A. Weiss, Michael S. Strano

Diabetes Aug 2020, 69 (8) 1815-1826; DOI: 10.2337/db19-0879
You have access
Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice
Xiaodong Sun, Fang Han, Qingguo Lu, Xuan Li, Di Ren, Jingwen Zhang, Ying Han, Yang K. Xiang, Ji Li

Diabetes Jun 2020, 69 (6) 1292-1305; DOI: 10.2337/db19-0991
Open Access
MG53 Does Not Manifest the Development of Diabetes in db/db Mice
Qiang Wang, Zehua Bian, Qiwei Jiang, Xiaoliang Wang, Xinyu Zhou, Ki Ho Park, Willa Hsueh, Bryan A. Whitson, Erin Haggard, Haichang Li, Ken Chen, Chuanxi Cai, Tao Tan, Hua Zhu, Jianjie Ma

Diabetes May 2020, 69 (5) 1052-1064; DOI: 10.2337/db19-0807

Main menu

User menu

Search

More articles from Pharmacology and Therapeutics

Pages

Navigate

More Information

Other ADA Resources